Dixon Hubard Feinour & Brown Inc Amgen Inc Transaction History

Dixon Hubard Feinour & Brown Inc

$842 Million
Q2 2022

A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Amgen Inc stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 4,854 shares of AMGN stock, worth $1.41 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

4,854

Previous 4,819 0.73%

Holding current value

$1.41 Million

Previous $1.17 Million 1.37%

% of portfolio

0.14%

Previous 0.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$230.71 - $256.74 $8,074 - $8,985	35 Added 0.73%	4,854 $1.18 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $21,927 - $24,257	100 Added 2.12%	4,819 $1.17 Million
Q4 2021 Jan 10, 2022	BUY	$198.88 - $227.6 $687,727 - $787,040	3,458 Added 274.23%	4,719 $1.06 Million
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $64,317 - $75,356	303 Added 31.63%	1,261 $268,000
Q2 2021 Aug 23, 2021	SELL	$233.58 - $259.14 $58,862 - $65,303	-252 Reduced 20.83%	958 $234,000
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $13,055 - $16,020	-66 Reduced 5.17%	1,210 $309,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $20,957 - $27,795	-115 Reduced 8.27%	1,276 $259,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $56,763 - $72,960	300 Added 27.5%	1,391 $335,000
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $1,044 - $1,251	-6 Reduced 0.55%	1,091 $211,000
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $19,837 - $23,253	-119 Reduced 9.79%	1,097 $202,000
Q1 2019 May 17, 2019	BUY	$180.87 - $203.88 $23,693 - $26,708	131 Added 12.07%	1,216 $231,000
Q2 2018 Jul 25, 2018	BUY	$166.05 - $186.51 $180,164 - $202,363	1,085 New	1,085 $200,000
Q4 2017 Feb 20, 2018	SELL	$168.79 - $188.59 $5.91 Million - $6.61 Million	-35,027 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $5.86 Million - $6.69 Million	35,027	35,027 $6.53 Million

Others Institutions Holding AMGN

# of Institutions

3,278

Shares Held

442M

Call Options Held

6.15M

Put Options Held

7.25M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.

Account

Dixon Hubard Feinour & Brown Inc Amgen Inc Transaction History